Corrigendum: Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors
oleh: Francesca Arezzo, Francesca Arezzo, Gaia Giannone, Daniele Castaldo, Giulia Scotto, Valentina Tuninetti, Margherita Turinetto, Michele Bartoletti, Serafina Mammoliti, Grazia Artioli, Giorgia Mangili, Vanda Salutari, Domenica Lorusso, Gennaro Cormio, Gennaro Cormio, Vera Loizzi, Vera Loizzi, Claudio Zamagni, Antonella Savarese, Massimo Di Maio, Graziana Ronzino, Carmela Pisano, Sandro Pignata, Giorgio Valabrega
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2024-01-01 |
Deskripsi
Subjek
endometrial cancer; molecular classification; immune checkpoint inhibitors; dostarlimab; pembrolizumab plus lenvatinib